Shareholder Cao Xiaochun of Hangzhou Tigermed Consulting (03347) collectively reduced holdings of 347,600 shares.

Hangzhou Tigermed Consulting (03347) announced that on November 18, 2025, the company received a notification letter from Ms. Cao Xiaochun, a shareholder with more than 5% of the shares, director, and general manager, regarding the completion of the share reduction plan. As of November 18, 2025, Ms. Cao Xiaochun's share reduction plan has expired, during which she has reduced a total of 347,600 shares, accounting for 0.0406% of the company's total share capital after excluding the shares in the repurchase account, and 0.0475% of the company's total A-shares.